US Stock MarketDetailed Quotes

Haemonetics (HAE)

Watchlist
  • 59.930
  • +0.310+0.52%
Close Apr 24 15:59 ET
  • 59.930
  • 0.0000.00%
Post 17:25 ET
2.79BMarket Cap16.51P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Haemonetics (HAE) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Dec 27, 2025
(Q2)Sep 27, 2025
(Q1)Jun 28, 2025
(FY)Mar 29, 2025
(Q4)Mar 29, 2025
(Q3)Dec 28, 2024
(Q2)Sep 28, 2024
(Q1)Jun 29, 2024
(FY)Mar 30, 2024
(Q4)Mar 30, 2024
Total revenue
-2.75%338.97M
-5.27%327.32M
-4.40%321.39M
3.95%1.36B
-3.70%330.6M
3.66%348.54M
8.59%345.51M
7.98%336.17M
12.01%1.31B
12.77%343.29M
Operating revenue
-2.75%338.97M
-5.27%327.32M
-4.40%321.39M
3.95%1.36B
-3.70%330.6M
3.66%348.54M
8.59%345.51M
7.98%336.17M
12.01%1.31B
12.77%343.29M
Cost of revenue
-11.88%136.58M
-16.13%132.57M
-19.91%129.15M
-0.91%611.87M
-17.82%137.55M
-2.14%155M
7.04%158.07M
11.93%161.25M
11.55%617.51M
12.97%167.38M
Gross profit
4.57%202.39M
3.90%194.74M
9.90%192.24M
8.30%748.96M
9.75%193.05M
8.82%193.55M
9.93%187.44M
4.58%174.92M
12.43%691.55M
12.58%175.91M
Operating expense
-0.18%134.27M
-4.26%127.67M
2.37%138.37M
5.70%547.77M
5.23%144.74M
1.99%134.52M
-1.37%133.35M
18.98%135.17M
12.80%518.25M
13.32%137.54M
Selling and administrative expenses
2.53%109.15M
-4.98%101.62M
2.28%110.72M
1.16%436.79M
3.48%115.14M
-4.70%106.46M
-7.26%106.95M
15.79%108.25M
14.63%431.78M
13.81%111.26M
Research and development costs
-10.37%14.19M
5.18%14.87M
12.54%16.26M
15.22%62.72M
15.44%18.31M
19.33%15.83M
11.64%14.14M
14.24%14.45M
8.59%54.44M
1.36%15.86M
Depreciation amortization depletion
-10.61%10.93M
-8.82%11.18M
-8.65%11.39M
50.67%48.26M
8.35%11.3M
76.96%12.23M
69.81%12.26M
66.88%12.47M
-1.87%32.03M
30.74%10.43M
-Depreciation and amortization
-10.61%10.93M
-8.82%11.18M
-8.65%11.39M
50.67%48.26M
8.35%11.3M
76.96%12.23M
69.81%12.26M
66.88%12.47M
-1.87%32.03M
30.74%10.43M
Operating profit
15.39%68.11M
24.01%67.08M
35.51%53.87M
16.09%201.19M
25.94%48.31M
28.39%59.03M
53.21%54.09M
-25.91%39.76M
11.34%173.3M
10.00%38.36M
Net non-operating interest income expense
18.56%-7.42M
-3.05%-7.21M
-225.10%-8.7M
25.13%-9.75M
90.84%-598K
-367.52%-9.11M
-183.00%-6.99M
436.25%6.96M
11.02%-13.02M
-148.35%-6.53M
Non-operating interest income
----
----
----
----
----
----
----
--6.96M
----
----
Non-operating interest expense
-18.56%7.42M
3.05%7.21M
--8.7M
-25.13%9.75M
-90.84%598K
367.52%9.11M
183.00%6.99M
----
-11.02%13.02M
148.35%6.53M
Other net income (expense)
-716K
-259.01%-8.58M
345.05%20.63M
23.02M
-2.39M
-2,303.93%-8.42M
Special income (charges)
---716K
-259.01%-8.58M
----
345.05%20.63M
--23.02M
--0
---2.39M
----
-2,303.93%-8.42M
----
-Less：Restructuring and merger&acquisition
----
----
----
---23.02M
----
----
----
----
--0
----
-Less:Impairment of capital assets
--716K
259.01%8.58M
----
-77.05%2.39M
--0
--0
--2.39M
----
--10.42M
----
-Gain on sale of business
----
----
----
--0
----
----
----
----
423.56%2M
----
Income before tax
20.15%59.98M
14.72%51.29M
-3.31%45.17M
39.64%212.07M
202.11%70.74M
13.37%49.92M
36.16%44.7M
-9.45%46.71M
7.40%151.87M
-28.24%23.41M
Income tax
22.64%15.24M
15.89%12.6M
33.55%11.14M
29.40%44.39M
318.64%12.76M
-2.85%12.42M
37.22%10.87M
-20.93%8.34M
31.94%34.31M
-6.04%3.05M
Net income
19.33%44.74M
14.34%38.68M
-11.32%34.03M
42.64%167.68M
184.68%57.98M
20.02%37.49M
35.82%33.83M
-6.50%38.37M
1.87%117.56M
-30.68%20.37M
Net income continuous Operations
19.33%44.74M
14.34%38.68M
-11.32%34.03M
42.64%167.68M
184.68%57.98M
20.02%37.49M
35.82%33.83M
-6.50%38.37M
1.87%117.56M
-30.68%20.37M
Minority interest income
Net income attributable to the parent company
19.33%44.74M
14.34%38.68M
-11.32%34.03M
42.64%167.68M
184.68%57.98M
20.02%37.49M
35.82%33.83M
-6.50%38.37M
1.87%117.56M
-30.68%20.37M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
19.33%44.74M
14.34%38.68M
-11.32%34.03M
42.64%167.68M
184.68%57.98M
20.02%37.49M
35.82%33.83M
-6.50%38.37M
1.87%117.56M
-30.68%20.37M
Basic earnings per share
28.00%0.96
22.73%0.81
-5.33%0.71
43.53%3.33
193.91%1.1786
20.97%0.75
34.69%0.66
-7.41%0.75
2.20%2.32
-31.15%0.401
Diluted earnings per share
28.38%0.95
22.73%0.81
-5.41%0.7
44.54%3.31
192.50%1.17
21.31%0.74
37.50%0.66
-7.50%0.74
2.23%2.29
-29.82%0.4
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q3)Dec 27, 2025(Q2)Sep 27, 2025(Q1)Jun 28, 2025(FY)Mar 29, 2025(Q4)Mar 29, 2025(Q3)Dec 28, 2024(Q2)Sep 28, 2024(Q1)Jun 29, 2024(FY)Mar 30, 2024(Q4)Mar 30, 2024
Total revenue -2.75%338.97M-5.27%327.32M-4.40%321.39M3.95%1.36B-3.70%330.6M3.66%348.54M8.59%345.51M7.98%336.17M12.01%1.31B12.77%343.29M
Operating revenue -2.75%338.97M-5.27%327.32M-4.40%321.39M3.95%1.36B-3.70%330.6M3.66%348.54M8.59%345.51M7.98%336.17M12.01%1.31B12.77%343.29M
Cost of revenue -11.88%136.58M-16.13%132.57M-19.91%129.15M-0.91%611.87M-17.82%137.55M-2.14%155M7.04%158.07M11.93%161.25M11.55%617.51M12.97%167.38M
Gross profit 4.57%202.39M3.90%194.74M9.90%192.24M8.30%748.96M9.75%193.05M8.82%193.55M9.93%187.44M4.58%174.92M12.43%691.55M12.58%175.91M
Operating expense -0.18%134.27M-4.26%127.67M2.37%138.37M5.70%547.77M5.23%144.74M1.99%134.52M-1.37%133.35M18.98%135.17M12.80%518.25M13.32%137.54M
Selling and administrative expenses 2.53%109.15M-4.98%101.62M2.28%110.72M1.16%436.79M3.48%115.14M-4.70%106.46M-7.26%106.95M15.79%108.25M14.63%431.78M13.81%111.26M
Research and development costs -10.37%14.19M5.18%14.87M12.54%16.26M15.22%62.72M15.44%18.31M19.33%15.83M11.64%14.14M14.24%14.45M8.59%54.44M1.36%15.86M
Depreciation amortization depletion -10.61%10.93M-8.82%11.18M-8.65%11.39M50.67%48.26M8.35%11.3M76.96%12.23M69.81%12.26M66.88%12.47M-1.87%32.03M30.74%10.43M
-Depreciation and amortization -10.61%10.93M-8.82%11.18M-8.65%11.39M50.67%48.26M8.35%11.3M76.96%12.23M69.81%12.26M66.88%12.47M-1.87%32.03M30.74%10.43M
Operating profit 15.39%68.11M24.01%67.08M35.51%53.87M16.09%201.19M25.94%48.31M28.39%59.03M53.21%54.09M-25.91%39.76M11.34%173.3M10.00%38.36M
Net non-operating interest income expense 18.56%-7.42M-3.05%-7.21M-225.10%-8.7M25.13%-9.75M90.84%-598K-367.52%-9.11M-183.00%-6.99M436.25%6.96M11.02%-13.02M-148.35%-6.53M
Non-operating interest income ------------------------------6.96M--------
Non-operating interest expense -18.56%7.42M3.05%7.21M--8.7M-25.13%9.75M-90.84%598K367.52%9.11M183.00%6.99M-----11.02%13.02M148.35%6.53M
Other net income (expense) -716K-259.01%-8.58M345.05%20.63M23.02M-2.39M-2,303.93%-8.42M
Special income (charges) ---716K-259.01%-8.58M----345.05%20.63M--23.02M--0---2.39M-----2,303.93%-8.42M----
-Less：Restructuring and merger&acquisition ---------------23.02M------------------0----
-Less:Impairment of capital assets --716K259.01%8.58M-----77.05%2.39M--0--0--2.39M------10.42M----
-Gain on sale of business --------------0----------------423.56%2M----
Income before tax 20.15%59.98M14.72%51.29M-3.31%45.17M39.64%212.07M202.11%70.74M13.37%49.92M36.16%44.7M-9.45%46.71M7.40%151.87M-28.24%23.41M
Income tax 22.64%15.24M15.89%12.6M33.55%11.14M29.40%44.39M318.64%12.76M-2.85%12.42M37.22%10.87M-20.93%8.34M31.94%34.31M-6.04%3.05M
Net income 19.33%44.74M14.34%38.68M-11.32%34.03M42.64%167.68M184.68%57.98M20.02%37.49M35.82%33.83M-6.50%38.37M1.87%117.56M-30.68%20.37M
Net income continuous Operations 19.33%44.74M14.34%38.68M-11.32%34.03M42.64%167.68M184.68%57.98M20.02%37.49M35.82%33.83M-6.50%38.37M1.87%117.56M-30.68%20.37M
Minority interest income
Net income attributable to the parent company 19.33%44.74M14.34%38.68M-11.32%34.03M42.64%167.68M184.68%57.98M20.02%37.49M35.82%33.83M-6.50%38.37M1.87%117.56M-30.68%20.37M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 19.33%44.74M14.34%38.68M-11.32%34.03M42.64%167.68M184.68%57.98M20.02%37.49M35.82%33.83M-6.50%38.37M1.87%117.56M-30.68%20.37M
Basic earnings per share 28.00%0.9622.73%0.81-5.33%0.7143.53%3.33193.91%1.178620.97%0.7534.69%0.66-7.41%0.752.20%2.32-31.15%0.401
Diluted earnings per share 28.38%0.9522.73%0.81-5.41%0.744.54%3.31192.50%1.1721.31%0.7437.50%0.66-7.50%0.742.23%2.29-29.82%0.4
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -